Research study Program year 2025 Source: CMS Open Payments

Ocrelizumab Vaccination Study

Research payments

$2,772,742

190 payments

Through program year 2025, $2,772,742 in research payments was reported against Ocrelizumab Vaccination Study, across 190 payments.

Paid by (largest first): Genentech, Inc.; F. Hoffmann-La Roche AG
ClinicalTrials.gov: No trial number was reported for this study

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$361	1
2024	Research	$90,205	9
2023	Research	$65,349	8
2022	Research	$314,773	29
2021	Research	$689,913	46
2020	Research	$674,269	47
2019	Research	$937,871	50

Breakdown

Who paid Research payments · program years 2019–2025

Genentech, Inc. $2,756,843 181 payments
F. Hoffmann-La Roche AG $15,899 9 payments

Who received the money Research payments · program years 2019–2025

Neurology Associates PA Organisation paid for research $390,651 16 payments
Cleveland Clinic Hospital Teaching hospital · OH $377,121 9 payments
University of South Florida Board of Trustees Organisation paid for research $365,773 21 payments
Schapiro Center For Multiple Sclerosis Organisation paid for research $217,512 5 payments
North Central Neurology Associates Pc Organisation paid for research $156,269 7 payments
Neurology Clinic Pc Organisation paid for research $130,384 2 payments
Deren Huang Neurology · Newark, OH $121,916 3 payments
Territory Neurology And Research Institute Organisation paid for research $114,722 2 payments
Neurology Clinic Pc MD Organisation paid for research $112,194 2 payments
Central Texas Neurology Consultants PA Organisation paid for research $93,626 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.